HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Screening for Executive Dysfunction in Late-Life Depression: Utility of Trail Making Test and Self-Report Measures.

AbstractOBJECTIVE:
Prior work suggests executive dysfunction (ED) on the Stroop Color and Word Test (SCWT) and the Mattis Dementia Rating Scale-2 Initiation/Perseveration subscale (DRS IP) predicts poor antidepressant response in late-life depression. This study examined if either patient perception of ED or the Trail Making Test Part B (TMT-B) could identify patients with impairment on the SCWT or DRS IP.
METHODS:
Patients were 65 or older and had a diagnosis of major depression without dementia. Cognition was assessed with the TMT-B, the SCWT, and the DRS IP. A self-reported Perceived Deficits Questionnaire (PDQ) subscale assessed patients' perceptions of ED.
RESULTS:
In 247 participants (mean age 71.3 years), the PDQ subscale was not associated with test performance. The sensitivity of the TMT-B in identifying impairment on the SCWT or DRS IP was low (35% and 23%, respectively).
CONCLUSION:
Neither the TMT-B nor self-reports are useful screening tools for ED on the SCWT or DRS IP.
AuthorsDavid Bickford, Ruth T Morin, Dan Catalinotto, R Scott Mackin, J Craig Nelson
JournalThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry (Am J Geriatr Psychiatry) Vol. 26 Issue 10 Pg. 1091-1094 (10 2018) ISSN: 1545-7214 [Electronic] England
PMID30072308 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Aging (physiology)
  • Cognitive Dysfunction (diagnosis, epidemiology)
  • Comorbidity
  • Depressive Disorder, Major (epidemiology, physiopathology)
  • Executive Function (physiology)
  • Female
  • Geriatric Assessment
  • Humans
  • Male
  • Self Report (standards)
  • Trail Making Test (standards)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: